Prevention of UV-carcinogenesis through DNA repair-dependent immunomodulation

通过 DNA 修复依赖性免疫调节预防紫外线致癌

基本信息

项目摘要

DESCRIPTION (provided by applicant): The goals of the proposed studies are to: (1) Identify the mechanisms by which silymarin, a phytochemical obtained from milk thistle (Silybum marianum L.), ameliorates ultraviolet (UV) radiation-induced immunosuppression and DNA damage; and (2) Determine the contribution of these mechanisms to silymarin-mediated prevention of skin cancer. Both UV-induced DNA damage, in the form of cyclobutane pyrimidine dimers (CPDs), and immune suppression have been shown to be associated with an increased risk of skin cancer. We have demonstrated that topical treatment with silymarin provides significant protection against both UV-induced immunosuppression and carcinogenesis in an in vivo mouse model. UV irradiation is known to impair the function of dendritic cells and effector T cells but induce suppressor T cells. Furthermore, UV-induced DNA damage, predominantly the formation of CPDs, is an important molecular trigger for UV-mediated immunosuppression. We have demonstrated that silymarin has the ability to enhance the removal or repair of CPD+ cells in UV-exposed skin, and inhibits UVB-induced suppression of the contact hypersensitivity response in mice. Our preliminary data further indicate that silymarin can enhance the removal of CPDs in UV-exposed dendritic cells and restore dendritic cell-mediated activities including stimulation of T cells. However, silymarin mediated inhibition of UV-induced immunosuppression is abolished in mice that have defect in DNA repair. Collectively, these data implicate key links between the ability of silymarin to inhibit UV-induced immunosuppression and its ability to prevent photocarcinogenesis. Our hypothesis is that the repair of UVB-induced DNA damage by silymarin is critical for its chemopreventive effects on UV-induced immunosuppression and photocarcinogenesis. We propose four inter-related Specific Aims in which we will use genetically modified mouse model, including nucleotide excision repair-deficient mice: (1) Determine whether silymarin inhibits the development of UV-induced tolerogenic dendritic cells through restoration of dendritic cell activity; (2) Determine whether silymarin- induced inhibition of UV-induced immunosuppression occurs through enhancement of T-cell activation, (3) Determine whether silymarin inhibits the development of UV-induced regulatory T cells; and (4) Determine whether silymarin inhibition of photocarcinogenesis is mediated through DNA repair. The proposed studies should identify the mechanisms by which silymarin acts to correct UV-induced immunosuppression in photocarcinogenesis. We address a major public health concern as overexposure of the human skin to solar UV radiation is the major etiologic factor for the development of melanoma and non-melanoma skin cancers in the United States. The development of new strategies using silymarin may help to reduce the risk of skin cancer in humans. PUBLIC HEALTH RELEVANCE: Chronic exposure of the skin to solar ultraviolet (UV) radiation induces multiple adverse effects including the risk of skin cancer development. In vitro and in vivo studies have indicated that silymarin, a plant flavonoid obtained from milk thistle, possesses potent anti-photocarcinogenic activity. In the current application, we will determine the molecular mechanism of prevention of photocarcinogenesis by silymarin. This study will also highlight that rapid repair of UVB-induced DNA damage by silymarin will result in the enhancement or restoration of immune system and that will lead to the prevention of UV-carcinogenesis. The generation of new knowledge will provide novel insights into the mechanisms by which silymarin can either correct, or compensate for, the UV-induced damage that triggers or promotes photocarcinogenesis.
描述(由申请人提供):拟议的研究的目标是:(1)确定从牛奶蓟(Silybum Marianum L.)获得的植物化学的机制,可改善紫外线(UV)辐射诱导的免疫抑制和DNA损伤; (2)确定这些机制对面叶蛋白介导的皮肤癌的预防的贡献。两种紫外线诱导的DNA损伤,以环丁烷嘧啶二聚体(CPD)的形式,并且免疫抑制均与皮肤癌风险增加有关。我们已经证明,用水飞莲蛋白的局部处理为在体内小鼠模型中对紫外线诱导的免疫抑制和致癌作用提供了显着保护。已知紫外线照射会损害树突状细胞和效应T细胞的功能,但会诱导抑制T细胞。此外,紫外线诱导的DNA损伤主要是CPD的形成,是紫外线介导的免疫抑制的重要分子触发因素。我们已经证明,水莲蛋白具有增强紫外线暴露皮肤中CPD+细胞的去除或修复的能力,并抑制UVB诱导的小鼠接触超敏反应的抑制。我们的初步数据进一步表明,水莲蛋白可以增强紫外线暴露的树突状细胞中CPD的去除,并恢复树突状细胞介导的活性,包括刺激T细胞。然而,在DNA修复缺陷的小鼠中消除了甲略生蛋白介导的对紫外线诱导的免疫抑制的抑制作用。总的来说,这些数据暗示了二合作蛋白抑制紫外线诱导的免疫抑制的能力及其预防光致衰变的能力之间的关键联系。我们的假设是,通过水莲蛋白对UVB诱导的DNA损伤的修复对于其化学预防对紫外线诱导的免疫抑制和光钙局发生的作用至关重要。我们提出了四个相互关联的特定目的,其中我们将使用遗传修饰的小鼠模型,包括核苷酸切除修复缺陷型小鼠:(1)确定水硅林是否通过恢复树枝状细胞活性来抑制紫外线诱导的阳离子耐受性树突状细胞的发展; (2)确定是通过增强T细胞活化的紫外线诱导的紫外线诱导的免疫抑制作用的抑制作用,(3)确定甲硅烷基素是否抑制了紫外线诱导的调节性T细胞的发展; (4)确定水莲蛋白是否通过DNA修复介导光钙局发生的抑制作用。拟议的研究应确定水莲蛋白起作用在光粘连生成中纠正紫外线诱导的免疫抑制的机制。我们解决了一个主要的公共卫生问题,因为人类皮肤过度暴露于太阳紫外线辐射是美国黑色素瘤和非黑色素瘤皮肤癌的发展的主要病因因素。使用水硅林制定新策略可能有助于降低人类皮肤癌的风险。 公共卫生相关性:皮肤长期暴露于太阳能紫外线(UV)辐射会引起多种不良反应,包括皮肤癌发育风险。体外研究和体内研究表明,从牛奶蓟获得的植物类黄酮蛋白具有有效的抗磷酸癌活性。在当前的应用中,我们将确定由甲硅烷基林蛋白预防光钙局发生的分子机制。这项研究还将强调,迅速修复UVB诱导的DNA损伤会导致免疫系统的增强或恢复,这将导致预防紫外线 - 卡霉素发生。新知识的产生将提供新的见解,以纠正或补偿触发或促进光碳纤维生成的紫外线诱导的损伤的机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SANTOSH KUMAR KATIYAR其他文献

SANTOSH KUMAR KATIYAR的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SANTOSH KUMAR KATIYAR', 18)}}的其他基金

Prevention of UV-carcinogenesis through DNA methylation-dependent immunomodulation
通过 DNA 甲基化依赖性免疫调节预防紫外线致癌
  • 批准号:
    8883008
  • 财政年份:
    2015
  • 资助金额:
    $ 33.17万
  • 项目类别:
Prevention of UV-carcinogenesis through DNA methylation-dependent immunomodulation
通过 DNA 甲基化依赖性免疫调节预防紫外线致癌
  • 批准号:
    9070629
  • 财政年份:
    2015
  • 资助金额:
    $ 33.17万
  • 项目类别:
Proanthocyanidins,Novel bioactive components for prevention of melanoma invasion
原花青素,预防黑色素瘤侵袭的新型生物活性成分
  • 批准号:
    8442533
  • 财政年份:
    2013
  • 资助金额:
    $ 33.17万
  • 项目类别:
Proanthocyanidins,Novel bioactive components for prevention of melanoma invasion
原花青素,预防黑色素瘤侵袭的新型生物活性成分
  • 批准号:
    8601917
  • 财政年份:
    2013
  • 资助金额:
    $ 33.17万
  • 项目类别:
Prevention of photocarcinogenesis by dietary immunomodulation
通过饮食免疫调节预防光致癌
  • 批准号:
    8431273
  • 财政年份:
    2012
  • 资助金额:
    $ 33.17万
  • 项目类别:
Prevention of photocarcinogenesis by dietary immunomodulation
通过饮食免疫调节预防光致癌
  • 批准号:
    8698300
  • 财政年份:
    2012
  • 资助金额:
    $ 33.17万
  • 项目类别:
Prevention of photocarcinogenesis by dietary immunomodulation
通过饮食免疫调节预防光致癌
  • 批准号:
    8240922
  • 财政年份:
    2012
  • 资助金额:
    $ 33.17万
  • 项目类别:
Prevention of photocarcinogenesis by dietary immunomodulation
通过饮食免疫调节预防光致癌
  • 批准号:
    8803280
  • 财政年份:
    2012
  • 资助金额:
    $ 33.17万
  • 项目类别:
Epigenetic modulation by green tea in prevention of photocarcinogenesis
绿茶的表观遗传调节预防光致癌
  • 批准号:
    7895438
  • 财政年份:
    2010
  • 资助金额:
    $ 33.17万
  • 项目类别:
Epigenetic modulation by green tea in prevention of photocarcinogenesis
绿茶的表观遗传调节预防光致癌
  • 批准号:
    8033727
  • 财政年份:
    2010
  • 资助金额:
    $ 33.17万
  • 项目类别:

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Reproductive history and later-life brain health: The Bogalusa Heart Study
生殖史和晚年大脑健康:Bogalusa 心脏研究
  • 批准号:
    10736169
  • 财政年份:
    2023
  • 资助金额:
    $ 33.17万
  • 项目类别:
Mitoquinone/mitoquinol mesylate as oral and safe Postexposure Prophylaxis for Covid-19
米托醌/甲磺酸米托喹诺作为 Covid-19 的口服且安全的暴露后预防
  • 批准号:
    10727092
  • 财政年份:
    2023
  • 资助金额:
    $ 33.17万
  • 项目类别:
Gabapentinoid/opioid mixtures: abuse and toxicity
加巴喷丁/阿片类混合物:滥用和毒性
  • 批准号:
    10639396
  • 财政年份:
    2023
  • 资助金额:
    $ 33.17万
  • 项目类别:
Physical Frailty and Symptom Monitoring and Management Behaviors in Heart Failure (PRISM-HF)
心力衰竭的身体虚弱和症状监测和管理行为 (PRISM-HF)
  • 批准号:
    10740609
  • 财政年份:
    2023
  • 资助金额:
    $ 33.17万
  • 项目类别:
Class II Human Leukocyte Antigen biologics for antibody-mediated graft rejection.
用于抗体介导的移植物排斥反应的 II 类人类白细胞抗原生物制剂。
  • 批准号:
    10598931
  • 财政年份:
    2023
  • 资助金额:
    $ 33.17万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了